Asia-Pacific Blood Transfusion Diagnostics Market Forecast to 2028

Report Code : BMIRE00027402 | Region : Asia Pacific | Industry : Medical Device | Published Date : 10/Nov/2022
Asia-Pacific Blood Transfusion Diagnostics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Instruments & Kits and Reagents), Application (Blood Grouping and Disease Screening), and End User (Hospitals, Diagnostic Laboratories, Blood Banks, and Plasma Fractionation Companies)

The APAC blood transfusion diagnostics market is expected to grow from US$ 875.20 million in 2022 to US$ 1,380.34 million by 2028. It is estimated to grow at a CAGR of 7.9% from 2022 to 2028.

Elevated Healthcare Expenditure in Emerging Economies to Boost Market in Coming Years

Healthcare budget allocations help countries strengthen workforces and improve this sector's productivity, thereby contributing to economic performance. Rapid economic developments allow developing countries to raise their healthcare expenditures, enabling them to establish better medical service infrastructure by leveraging technological advancements. The Government of India, through its National Health Authority agency, implemented Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) in 2019. This scheme has facilitated free/affordable treatment for cancer patients in the country. As per the data published by the National Health Authority of India, ~470,133 cancer cases were treated under AB-PMJAY in 2019. Such initiatives are likely to provide lucrative opportunities for companies in the blood transfusion diagnostics market to introduce advanced technologies for the blood transfusion diagnostics market in Asia Pacific.

Market Overview

China dominated the blood transfusion diagnostics market in Asia Pacific in 2022. The market growth in China is attributed to the increased use of advanced technologies in blood-related diagnoses, followed by a surge in the number of blood donation camps and blood banks in the country. The nation has a blood donation law in place that allows voluntary unpaid blood donation, and the donated blood can only be used for clinical practice. China's National Health Commission recorded 15.53 million blood donations in 2020, despite the pandemic-related restrictions. This figure is 40-times more than that recorded in 1998. According to Xinhua news, from January to April 2021, 5.12 million blood donations were registered nationwide. Therefore, the increasing number of blood donations for clinical use leads to high demand for blood transfusion diagnostics to screen the blood groups.

APAC Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

APAC Blood Transfusion Diagnostics Market Segmentation

The APAC blood transfusion diagnostics market is segmented based on product, application, end user, and country.

Based on product, the APAC blood transfusion diagnostics market is bifurcated into instruments & kits and reagents. The instruments & kits segment held the larger market share in 2022. Based on application, the APAC blood transfusion diagnostics market is bifurcated into blood grouping and disease screening. The disease screening segment held the larger market share in 2022. Based on end user, the APAC blood transfusion diagnostics market is segmented into hospitals, diagnostic laboratories, blood banks, and plasma fractionation companies. The blood banks segment dominated the market in 2022. Based on country, the APAC blood transfusion diagnostics market has been categorized into China, India, Japan, South Korea, Australia, and Rest of APAC. Our regional analysis states that China dominated the market in 2022.

Abbott; BAG Diagnostics GmbH; Bio-Rad Laboratories, Inc.; DiaSorin S.p.A.; F. Hoffmann-La Roche Ltd; Grifols, S.A.; Immucor, Inc.; Ortho Clinical Diagnostics (QuidelOrtho Corporation); Quotient Limited; and Thermo Fisher Scientific Inc. are the leading companies operating in the APAC blood transfusion diagnostics market.

The List of Companies - Asia-Pacific Blood Transfusion Diagnostics Market

● Abbott

● BAG Diagnostics GmbH

● Bio-Rad Laboratories, Inc.

● DiaSorin S.p.A.

● F. Hoffmann-La Roche Ltd      

● Grifols, S.A.

● Immucor, Inc.  

● Ortho Clinical Diagnostics (QuidelOrtho Corporation)

● Quotient Limited

● Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 APAC Blood Transfusion Diagnostics Market – By Product

1.3.2 APAC Blood Transfusion Diagnostics Market – By Application

1.3.3 APAC Blood Transfusion Diagnostics Market – By End User

1.3.4 APAC Blood Transfusion Diagnostics Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. APAC Blood Transfusion Diagnostics Market – Market Landscape

4.1 Overview

4.2 APAC PEST Analysis

4.3 Experts Opinion

5. APAC Blood Transfusion Diagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rapid Increase in Chronic Diseases

5.1.2 Need for Blood Transfusion due to Rise in Organ Transplants Surgeries

5.2 Market Restraints

5.2.1 Problems Associated with Blood Transfusion Services

5.3 Market Opportunities

5.3.1 Elevated Healthcare Expenditure in Emerging Economies

5.4 Future Trends

5.4.1 Technological Developments in Blood Transfusion Diagnostics

5.5 Impact Analysis

6. Blood Transfusion Diagnostics Market– APAC Analysis

6.1 APAC Blood Transfusion Diagnostics Market Revenue Forecast and Analysis

7. APAC Blood Transfusion Diagnostics Market Analysis – By Product

7.1 Overview

7.2 APAC Blood Transfusion Diagnostics Market Revenue Share, by Product (2021 and 2028)

7.3 Instruments and Kits

7.3.1 Overview

7.3.2 Instruments and Kits: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

7.4 Reagents

7.4.1 Overview

7.4.2 Reagents: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

8. APAC Blood Transfusion Diagnostics Market Analysis – By Application

8.1 Overview

8.2 APAC Blood Transfusion Diagnostics Market Revenue Share, by Application (2021 and 2028)

8.3 Disease Screening

8.3.1 Overview

8.3.2 Disease Screening: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

8.4 Blood Grouping

8.4.1 Overview

8.4.2 Blood Grouping: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9. APAC Blood Transfusion Diagnostics Market Analysis – By End User

9.1 Overview

9.2 APAC Blood Transfusion Diagnostics Market Share, by End User, 2021 and 2028, (%)

9.3 Blood Banks

9.3.1 Overview

9.3.2 Blood Banks: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)

9.4 Hospitals

9.4.1 Overview

9.4.2 Hospitals: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.5 Diagnostic Laboratories

9.5.1 Overview

9.5.2 Diagnostic Laboratories: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)

9.6 Plasma Fractionation Companies

9.6.1 Overview

9.6.2 Plasma Fractionation Companies: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)

10. APAC Blood Transfusion Diagnostics Market Analysis – Country Analysis

10.1 Overview

10.1.2 APAC: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)

10.1.2.1 China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

10.1.2.1.1 Overview

10.1.2.1.2 China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

10.1.2.1.3 China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

10.1.2.1.4 China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

10.1.2.1.5 China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

10.1.2.2 Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

10.1.2.2.1 Overview

10.1.2.2.2 Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

10.1.2.2.3 Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

10.1.2.2.4 Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

10.1.2.2.5 Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

10.1.2.3 India Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

10.1.2.3.1 Overview

10.1.2.3.2 India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

10.1.2.3.3 India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

10.1.2.3.4 India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

10.1.2.3.5 India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

10.1.2.4 South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

10.1.2.4.1 Overview

10.1.2.4.2 South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

10.1.2.4.3 South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

10.1.2.4.4 South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

10.1.2.4.5 South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

10.1.2.5 Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

10.1.2.5.1 Overview

10.1.2.5.2 Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

10.1.2.5.3 Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

10.1.2.5.4 Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

10.1.2.5.5 Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

10.1.2.6 Rest of APAC: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.6.1 Overview

10.1.2.6.2 Rest of APAC: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.6.3 Rest of APAC: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

10.1.2.6.4 Rest of APAC: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

10.1.2.6.5 Rest of APAC: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

11. Industry Landscape

11.1 Overview

11.2 Inorganic Growth Strategies

11.2.1 Overview

11.3 Organic Growth Strategies

11.3.1 Overview

12. Company Profiles

12.1 Grifols, S.A.

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 F. Hoffmann-La Roche Ltd

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Immucor, Inc.

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Bio-Rad Laboratories, Inc.

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Abbott

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Thermo Fisher Scientific Inc.

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Ortho Clinical Diagnostics (QuidelOrtho Corporation)

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 DiaSorin S.p.A.

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Quotient Limited

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 BAG Diagnostics GmbH

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES.

Table 1. APAC Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Mn)

Table 2. China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 3. China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 4. China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 5. Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 6. Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 7. Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 8. India: National Estimation of Blood Requirement in India (2018)

Table 9. India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 10. India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 11. India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 12. South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 13. South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 14. South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 15. Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 16. Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 17. Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 18. Rest of APAC: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 19. Rest of APAC: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 20. Rest of APAC: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 21. Recent Inorganic Growth Strategies

Table 22. Recent Organic Growth Strategies

Table 23. Glossary of Terms

The List of Companies - Asia-Pacific Blood Transfusion Diagnostics Market

● Abbott

● BAG Diagnostics GmbH

● Bio-Rad Laboratories, Inc.

● DiaSorin S.p.A.

● F. Hoffmann-La Roche Ltd      

● Grifols, S.A.

● Immucor, Inc.  

● Ortho Clinical Diagnostics (QuidelOrtho Corporation)

● Quotient Limited

● Thermo Fisher Scientific Inc.

Reason To Buy

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC blood transfusion diagnostics market.

● Highlights key business priorities to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the APAC blood transfusion diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the blood transfusion diagnostics market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(Asia-Pacific Blood Transfusion Diagnostics Market Forecast to 2028)
  • Single User Price $3,000$2,400
  • Site Price $4,000$3,200
  • Enterprise Price $5,000$4,000
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry